Page last updated: 2024-12-06

2',7'-dichlorofluorescein

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2',7'-dichlorofluorescein is a fluorescent dye that is widely used in biological research. It is a derivative of fluorescein, and its chemical structure is similar to that of fluorescein, with the addition of two chlorine atoms at the 2' and 7' positions. 2',7'-dichlorofluorescein is typically synthesized by reacting fluorescein with chlorine gas in the presence of a catalyst. 2',7'-dichlorofluorescein is a non-fluorescent compound in its protonated form, but it becomes highly fluorescent upon deprotonation. This property makes it useful for studying pH changes in cells and tissues. 2',7'-dichlorofluorescein has also been used as a probe for reactive oxygen species (ROS) such as hydrogen peroxide, superoxide, and hydroxyl radical. The reaction of 2',7'-dichlorofluorescein with ROS produces a fluorescent product, which can be detected using a fluorescent microscope. 2',7'-dichlorofluorescein is also used to detect the presence of reactive nitrogen species (RNS), such as nitric oxide. 2',7'-dichlorofluorescein is a valuable tool for studying a wide range of biological processes, including cell signaling, oxidative stress, and inflammation.'

2',7'-dichlorofluorescein: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID64944
CHEMBL ID1908059
CHEBI ID51596
SCHEMBL ID157703
MeSH IDM0113707

Synonyms (48)

Synonym
dichlorofluorescein
76-54-0
2',7'-dichloro-3',6'-dihydroxy-3h-spiro[2-benzofuran-1,9'-xanthen]-3-one
fluorescein 27
CHEBI:51596 ,
2',7'-dichlorofluorescein, ~90% (tlc), crystalline
2',7'-dichlorofluorescein, acs reagent
2',7'-dichlorofluorescein
2',7'-dichlorofluorescein, suitable for fluorescence, bioreagent, >=90% (t)
D0371
2',7'-dichloro-3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one
einecs 200-968-6
unii-56nqm5uzt1
56nqm5uzt1 ,
spiro(isobenzofuran-1(3h),9'-(9h)xanthen)-3-one, 2',7'-dichloro-3',6'-dihydroxy-
CHEMBL1908059
AKOS015902620
2',7'-dichlorofluorescein [mi]
2',7'-dichloro-3',6'-dihydroxyspiro(isobenzofuran-1(3h),9'-(9h)xanthen)-3-one
fluorescein 548
fluorescein-27
2',7'-dichloro-3,6-fluorandiol
d and c orange 25
d and c orange-25
fluorescein-548
spiro[isobenzofuran-1(3h),9'-[9h]xanthen]-3-one, 2',7'-dichloro-3',6'-dihydroxy-
SCHEMBL157703
DTXSID8058798
2,7-dichlorofluorescein
dichloro(r)fluorescein
mfcd00005047
2',7'-dichlorofluorescein acs grade
M05763
2',7'-dichloro-3',6'-dihydroxy-3h-spiro[isobenzofuran-1,9'-xanthen]-3-one
FT-0757261
spiro[isobenzofuran-1(3h),9'-[9h]xanthen]-3-one,2',7'-dichloro-3',6'-dihydroxy-
Q209286
AS-10301
N11910
2 inverted exclamation mark ,7 inverted exclamation mark -dichlorofluorescein
SY012994
CS-0169048
HY-W040143
CS-W020883
2',7'-bis(chloranyl)-3',6'-bis(oxidanyl)spiro[2-benzofuran-3,9'-xanthene]-1-one
IOQ ,
HY-W040143A
2',7'-dichlorofluorescein [fluorescent indicator]

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Dihydroergocryptine antagonized both the neuronal death produced by acute exposure to a toxic glutamate concentration as well as the normal age-dependent degeneration in culture."( Protection by dihydroergocryptine of glutamate-induced neurotoxicity.
Aleppo, G; Canonico, PL; Favit, A; Scapagnini, U; Sortino, MA, 1993
)
0.29
" These findings confirm a key role for glutathione in protecting cells from CsA-induced adverse effects and do not support a direct link between CsA-mediated ROS generation and adverse renal effects."( Diverse effects of natural antioxidants on cyclosporin cytotoxicity in rat renal tubular cells.
Capasso, G; Chiodini, P; Della Ragione, F; Di Gennaro, CI; Galletti, P; Indaco, S; Manna, C; Migliardi, V; Zappia, V, 2005
)
0.33

Bioavailability

ExcerptReferenceRelevance
" Bioavailability and cellular uptake of (-)-epicatechin are not yet fully characterized."( Amphiphilic properties of (-)-epicatechin and their significance for protection of cells against peroxynitrite.
Klotz, LO; Schroeder, P; Sies, H, 2003
)
0.32
" The bioavailability and efficacy of antioxidants in human corneal limbal epithelial (HCLE) cells were measured to determine whether antioxidants might be beneficial constituents of lubricant eye drops."( Bioavailability of antioxidants applied to stratified human corneal epithelial cells.
Koetje, LR; Mitchell, AK; Schotanus, MP; Stoddard, AR; Ubels, JL, 2013
)
0.39

Dosage Studied

ExcerptRelevanceReference
" MPTP produced a slight but significant decrease of DA only 4 hours post dosing on PND 23."( Age-related susceptibility to MPTP-induced neurotoxicity in mice.
Ali, SF; David, SN; Newport, GD, 1993
)
0.29
"5 cGy with linear dose-response curves."( Standardization of a fluorometric assay for measuring oxidative stress in irradiated cells.
Kennedy, AR; Wan, XS; Ware, JH; Zhou, Z, 2005
)
0.33
" A dose-response study suggested that quercetin showed protective effects against Abeta(1-42) toxicity by modulating oxidative stress at lower doses, but higher doses were not only non-neuroprotective but also toxic."( Protective effect of quercetin in primary neurons against Abeta(1-42): relevance to Alzheimer's disease.
Abdul, HM; Ansari, MA; Butterfield, DA; Joshi, G; Opii, WO, 2009
)
0.35
" Etoposide was administered at a dosage of 30 or 60 mg/kg."( Dominant lethal mutations of topoisomerase II inhibitors etoposide and merbarone in male mice: a mechanistic study.
Attia, SM, 2012
)
0.38
" CDFDA dosing models were based on simultaneous fitting of CDF levels in apical, basolateral, and intracellular compartments."( Cellular Pharmacokinetic Model-Based Analysis of Genistein, Glyceollin, and MK-571 Effects on 5 (and 6)-Carboxy-2',7'-Dichloroflourescein Disposition in Caco-2 Cells.
Drennen, C; Gorse, E; Stratford, RE, 2018
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
fluorochromeA fluorescent dye used to stain biological specimens.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
2-benzofurans
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID624612Specific activity of expressed human recombinant UGT1A92000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (324)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (4.63)18.7374
1990's92 (28.40)18.2507
2000's142 (43.83)29.6817
2010's64 (19.75)24.3611
2020's11 (3.40)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.58

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.58 (24.57)
Research Supply Index5.84 (2.92)
Research Growth Index5.18 (4.65)
Search Engine Demand Index50.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.58)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (0.88%)5.53%
Reviews6 (1.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other331 (97.35%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]